A detailed history of Pfg Investments, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 14,000 shares of ABCL stock, worth $41,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,000
Previous 15,100 7.28%
Holding current value
$41,300
Previous $44.7 Million 18.56%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$2.39 - $3.49 $2,629 - $3,839
-1,100 Reduced 7.28%
14,000 $36.4 Million
Q2 2024

Aug 06, 2024

SELL
$2.73 - $4.73 $4,095 - $7,095
-1,500 Reduced 9.04%
15,100 $44.7 Million
Q1 2024

Apr 22, 2024

BUY
$4.29 - $5.97 $71,214 - $99,102
16,600 New
16,600 $75.2 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.